SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits -- Ignore unavailable to you. Want to Upgrade?


To: BDR who wrote (21)1/15/1998 10:51:00 PM
From: MIKE DUBIS  Read Replies (1) | Respond to of 1016
 
Dale: the main VVUS post has the bulls toasting the glories of VVUS. The stock made it to 12! Even after the December collapse, the stock made it back to 14+ and is actually 2 points lower than it was then. I noticed that the post always concentrates on "upcoming events" which will propel the stock higher. How many times have we heard that before? After these events take place, the stock rarely goes up at all and often goes back down.



To: BDR who wrote (21)1/17/1998 12:30:00 PM
From: Linda Kaplan  Respond to of 1016
 
Dale,

I don't know the answer to many questions, but in regard to why the marketing campaign if they are selling all they can make, I believe that was addressed in the CC and press release. They expect that the second plant will be approved after they file for review on February 15, and they have been stockpiling product produced in that plant. They will be able to produce more after the second plant is approved and will also be able to ship stockpiled product. The campaign is planned to start at the end of January, if I recall correctly. If they can begin shipping end February from the second plant, they will have increased demand for the product in time for the availability of increased product.

Linda